Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 4/20 | 0.39 |
| ▸ | AHR | P35869 | 8/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23564151 | 0.86 | AHR (0.43) | AHR | |
| SCHEMBL21968791 | 0.83 | AHR (0.41) | TTRAHRMEN1CYP2C19KMT2A | |
| SCHEMBL19660360 | 0.82 | KDM4E (0.35) | MEN1CYP2C19KMT2ADYRK1AMAOA | |
| SCHEMBL22986636 | 0.81 | AHR (0.46) | TTRAHR | |
| SCHEMBL25073022 | 0.81 | ALOX5 (0.44) | MEN1CYP2C19KMT2ADYRK1AALOX5 | |
| SCHEMBL23987485 | 0.81 | KMT2A (0.34) | AHRMEN1CYP2C19KMT2ADYRK1A | |
| SCHEMBL21668671 | 0.80 | MEN1 (0.33) | MEN1CYP2C19KMT2ADYRK1A | |
| SCHEMBL21186703 | 0.80 | MEN1 (0.34) | AHRMEN1CYP2C19KMT2ADYRK1A | |
| SCHEMBL24033746 | 0.80 | TTR (0.38) | TTRAHR | |
| SCHEMBL23948019 | 0.79 | AHR (0.44) | TTRAHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873297-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-20210323948-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323948-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CCNL2, UBE2L3, OPRL1 | TTR 4378/4885AHR 39/4885MEN1 2258/4885 |
| US-11873297-B2 | Compound and organic light emitting device comprising the same | CCNL2, UBE2L3, ARL1 | TTR 4313/4885AHR 44/4885MEN1 1931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.